Thursday, October 2, 2008

Merck Scratches Controverisal Obesity Drug

The drug, taranabant, is in the same class as the Sanofi-Aventis drug sold in Europe under the brand name Acomplia. Both medicines are associated with psychiatric side effects.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)